Skip to main content
NMTC logo

NMTC · NEUROONE MEDICAL TECHNOLOGIES Corp

$1.67 -0.09 (-5.11%) At close · Jul 28
Market Cap
$14.53M
Shares
8.70M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Dave Rosa $1,154,436
Christoper Volker $687,373
Ron McClurg $523,822
Fiscal 2024
Executive Total
Dave Rosa $1,995,745
Christoper Volker $712,147
Ron McClurg $598,553
Fiscal 2023
Executive Total
Dave Rosa $989,558
Steve Mertens $457,714
Ron McClurg $390,157
Christoper Volker
Fiscal 2022
Executive Total
Dave Rosa $1,186,410
Steve Mertens $393,644
Ron McClurg $375,563
Fiscal 2021
Executive Total
Dave Rosa $1,889,351
Ron McClurg $522,529
Steve Mertens $371,138
Fiscal 2020
Executive Total
Dave Rosa $1,122,891
Steve Mertens $288,247
Mark Christianson $260,848
Ron McClurg
Fiscal 2019
Executive Total
Dave Rosa $558,166
Steve Mertens $291,391
Mark Christianson $259,493

Executive changes

Person Change Filed
Christopher Volker Appointed 2026-04-30
Ronald McClurg Retired 2026-04-30
Edward Andrle Appointed 2026-04-03
Jeffrey Mathiesen Appointed 2026-04-03
Key facts CIK 1500198 CUSIP 64130M308 13F (30d) 5 filings 5 filers Visit website Investor relations